Osiris Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

OSIR 4.31 -0.09 (-2.05%)
price chart
Osiris Therapeutics confirms interim CEO to lead Columbia-firm
Columbia-based Osiris Therapeutics Inc. has confirmed interim CEO Dwayne Montgomery as its new president and CEO, the biotechnology firm said Friday.
Grafix Demonstrates Positive Clinical Outcomes in Chronic Complex Wounds ...  Business Wire (press release)
Osiris Therapeutics Beset By Newer And Bigger Troubles
As expected, Osiris is now delinquent in filing its financials. As of its last filed financial statement, the company had approx. $1.23 in cash per share. (However, based on its historical cash burn, the cash balance has almost certainly declined ...
Osiris Therapeutics, Inc. Completes Restatement of 2014 Financial Statements
COLUMBIA, Md., March 27, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced ...
Osiris Therapeutics Inc. (OSIR) Soars 19.75% on March 28  Equities.com
Osiris Therapeutics Inc (NASDAQ:OSIR): An Attractive Turnaround Play  Insider Financial
Osiris Therapeutics names new CEO
Osiris Therapeutics, a troubled biotechnology firm based in Columbia, will get another new CEO in July. The company announced Monday that its board of directors has appointed Linda Palczuk, 55, as president and CEO, effective July 10.
Osiris Appoints Linda Palczuk to serve as its President & CEO  GlobeNewswire (press release)
Osiris Therapeutics names new CEO — again  Baltimore Business Journal
After Criminal Investigation, Osiris Is Finally Delisted
I generally only use the word "fraud" prominently once or twice a year. Osiris Therapeutics (NASDAQ:OSIR) was clearly one of those situations.
Osiris shares tumble on delisting notice from Nasdaq  Baltimore Business Journal
Osiris Therapeutics offers first glimpse into its books since last year
Osiris Therapeutics Inc. stock soared more than 20 percent Tuesday morning after it gave the first glimpse into its balance sheet since last year.
Osiris Therapeutics could be delisted from Nasdaq in March
Osiris Therapeutics Inc. isn't making any promises that it will meet the latest deadline handed down by the Nasdaq Stock Exchange to get current with its financial reporting.
Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of ...
COLUMBIA, Md., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that the study “A Comparative Outcomes Analysis Evaluating Clinical Effectiveness in Two Different Human Placental Membrane Products for ...
Delisting of Securities of Gordmans Stores, Inc., Unilife Corporation, Osiris ...
NEW YORK, April 27, 2017 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Gordmans Stores, Inc. Gordmans Stores, Inc.'s stock was suspended on March 22, 2017 and has not traded on Nasdaq ...
Osiris Therapeutics, Inc. (NASDAQ:OSIR) Making Waves Today
Shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) have been in the headlines as its price reached $4.4 at the conclusion of the most trading day.